Sign Up Today and Learn More About Ranovus Stock
Invest in or calculate the value of your shares in Ranovus or other pre-IPO companies through EquityZen's platform.
About Ranovus Stock
Founded
2012
Total Funding
68.5M
Industries
Software, Artificial Intelligence, Financial Services
RANOVUS, with operations in Ottawa, Canada, Mountain View, USA and Nuremberg, Germany, is a leading provider of multi-terabit interconnect solutions for datacenter and communications networks. RANOVUS’ highly scalable and disruptive portfolio includes Quantum Dot Multi-Wavelength Laser technology and advanced digital and photonics integrated circuit technologies that are setting a new industry benchmark for the lowest power dissipation, size and cost for the next generation of optical interconnect solutions.
Ranovus Press Mentions
Stay in the know about the latest news on Ranovus
Waveguide coupler
patents • May 04, 2025
DARPA Taps Cerebras and Ranovus for Military and Commercial Platform
insidehpc • Apr 03, 2025
Lightmatter says it's ready to ship chip-to-chip optical highways as early as summer
theregister • Apr 02, 2025
Cerebras Systems, Ranovus win $45 million US military deal to speed up chip connections
channelnewsasia • Apr 02, 2025
Waveguide photodetectors for reducing retro-reflection and increasing bandwidth
patents • Apr 02, 2025
Investors in Ranovus
Discover investors in Ranovus stock and explore their portfolio companies
Ranovus Management
Leadership team at Ranovus
Chief Executive Officer
Hamid Arabzadeh
Co-Founder & Chief Marketing and Sales Officer
Saeid Aramideh
Join now and verify your accreditation status to gain access to:
- Ranovus Current Valuation
- Ranovus Stock Price
- Ranovus Management
- Available deals in Ranovus and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ranovus Cap Table and Funding History by Share Class and Liquidity Preferences
- Ranovus Revenue and Financials
- Ranovus Highlights
- Ranovus Business Model
- Ranovus Risk Factors
- Ranovus Research Report from SACRA Research
Trading Ranovus Stock
How to invest in Ranovus stock?
Accredited investors can buy pre-IPO stock in companies like Ranovus through EquityZen funds. These investments are made available by existing Ranovus shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ranovus stock?
Shareholders can sell their Ranovus stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
